Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pavic

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
La Revue De Medecine Interne|February 16, 2005
[Common variable immunodeficiency with autoimmune manifestations: study of nine cases; interest of a peripheral B-cell compartment analysis in seven patients]M Pavic, P Sève, C Malcus, et al.
Inflammatory Bowel Diseases|October 1, 2014
Clostridium difficile and pediatric inflammatory bowel disease: a prospective, comparative, multicenter, ESPGHAN studyMassimo Martinelli, Caterina Strisciuglio, Gabor Veres, et al.
Radiation Oncology (London, England)|January 26, 2022
MR-guided adaptive stereotactic body radiotherapy (SBRT) of primary tumor for pain control in metastatic pancreatic ductal adenocarcinoma (mPDAC): an open randomized, multicentric, parallel group clinical trial (MASPAC)M Pavic, M Niyazi, L Wilke, et al.
La Revue De Medecine Interne|November 8, 2003
[Analysis of 12 cases of McArdle's disease diagnosed after 30 years]M Pavic, P Petiot, N Streichenberger, et al.
EJNMMI Research|July 15, 2020
FDG PET versus CT radiomics to predict outcome in malignant pleural mesothelioma patientsM Pavic, M Bogowicz, J Kraft, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 16, 2009
2008 SOR guidelines for the prevention and treatment of thrombosis associated with central venous catheters in patients with cancer: report from the working groupP Debourdeau, D Kassab Chahmi, G Le Gal, et al.
Frontiers in Oncology|December 12, 2022
PET/CT radiomics for prediction of hyperprogression in metastatic melanoma patients treated with immune checkpoint inhibitorsH S Gabryś, L Basler, S Burgermeister, et al.
BMC Immunology|October 1, 2016
Treatment with Hizentra in patients with primary and secondary immunodeficiencies: a real-life, non-interventional trialJ F Viallard, P Agape, V Barlogis, et al.
La Revue De Medecine Interne|March 8, 2011
[Practice guidelines of the use of bisphosphonates in solid tumours with bone metastases and in multiple myeloma]J F Brantus, C Roemer-Becuwe, P Cony-Makhoul, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 2, 2023
Interobserver agreement on definition of the target volume in stereotactic radiotherapy for pancreatic adenocarcinoma using different imaging modalitiesE Gkika, D Kostyszyn, T Fechter, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
La Revue De Medecine Interne|February 16, 2005
[Common variable immunodeficiency with autoimmune manifestations: study of nine cases; interest of a peripheral B-cell compartment analysis in seven patients]M Pavic, P Sève, C Malcus, et al.
Inflammatory Bowel Diseases|October 1, 2014
Clostridium difficile and pediatric inflammatory bowel disease: a prospective, comparative, multicenter, ESPGHAN studyMassimo Martinelli, Caterina Strisciuglio, Gabor Veres, et al.
Radiation Oncology (London, England)|January 26, 2022
MR-guided adaptive stereotactic body radiotherapy (SBRT) of primary tumor for pain control in metastatic pancreatic ductal adenocarcinoma (mPDAC): an open randomized, multicentric, parallel group clinical trial (MASPAC)M Pavic, M Niyazi, L Wilke, et al.
La Revue De Medecine Interne|November 8, 2003
[Analysis of 12 cases of McArdle's disease diagnosed after 30 years]M Pavic, P Petiot, N Streichenberger, et al.
EJNMMI Research|July 15, 2020
FDG PET versus CT radiomics to predict outcome in malignant pleural mesothelioma patientsM Pavic, M Bogowicz, J Kraft, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 16, 2009
2008 SOR guidelines for the prevention and treatment of thrombosis associated with central venous catheters in patients with cancer: report from the working groupP Debourdeau, D Kassab Chahmi, G Le Gal, et al.
Frontiers in Oncology|December 12, 2022
PET/CT radiomics for prediction of hyperprogression in metastatic melanoma patients treated with immune checkpoint inhibitorsH S Gabryś, L Basler, S Burgermeister, et al.
BMC Immunology|October 1, 2016
Treatment with Hizentra in patients with primary and secondary immunodeficiencies: a real-life, non-interventional trialJ F Viallard, P Agape, V Barlogis, et al.
La Revue De Medecine Interne|March 8, 2011
[Practice guidelines of the use of bisphosphonates in solid tumours with bone metastases and in multiple myeloma]J F Brantus, C Roemer-Becuwe, P Cony-Makhoul, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 2, 2023
Interobserver agreement on definition of the target volume in stereotactic radiotherapy for pancreatic adenocarcinoma using different imaging modalitiesE Gkika, D Kostyszyn, T Fechter, et al.
Pageof 8